Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

16.02
+0.34502.20%
Volume:259.26K
Turnover:4.12M
Market Cap:1.11B
PE:-17.27
High:16.10
Open:15.65
Low:15.64
Close:15.68
52wk High:29.65
52wk Low:12.26
Shares:69.58M
Float Shares:63.59M
Volume Ratio:0.64
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9274
EPS(LYR):-3.0424
ROE:-48.03%
ROA:-2.65%
PB:8.55
PE(LYR):-5.27

Loading ...

Tandem Diabetes Care Is Maintained at Overweight by Barclays

Dow Jones
·
May 11

Tandem Diabetes Care (TNDM) Gets a Buy from Barclays

TIPRANKS
·
May 11

Tandem Diabetes Care Charts Growth Amid Transition

TIPRANKS
·
May 09

Truist Cuts Price Target on Tandem Diabetes Care to $31 From $35, Keeps Buy Rating

MT Newswires Live
·
May 08

Stock Track | Tandem Diabetes Care Soars 8.23% in Pre-market on Strong Q1 Earnings Beat and Improved Outlook

Stock Track
·
May 08

Stock Track | Tandem Diabetes Care Soars 11.53% Intraday on Better-Than-Expected Q1 Results and Improved Outlook

Stock Track
·
May 08

Buy Rating Reaffirmed on Tandem Diabetes Care as Fundamentals Strengthen; $28 Price Target Maintained

TIPRANKS
·
May 08

Tandem Diabetes Care Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Stock Track | Tandem Diabetes Care Soars 9.64% After-Hours on Better-Than-Expected Q1 Results

Stock Track
·
May 08

Tandem Diabetes FY26 Q1 net loss narrows to $20.4 million; sales rise 5% to $247.2 million

Reuters
·
May 08

BRIEF-Tandem Diabetes Care Q1 Gross Margin 55%

Reuters
·
May 08

Tandem Diabetes Care Inc - Reports Q1 2026 Results and Reaffirms 2026 Financial Guidance

THOMSON REUTERS
·
May 08

Earning Preview: Tandem Diabetes Care this quarter’s revenue is expected to increase by 9.19%, and institutional views are bullish

Earnings Agent
·
Apr 30

Tandem Diabetes Care to present at BofA Securities Health Care Conference

Reuters
·
Apr 30

Tandem Diabetes Care’s Control-Iq+ Automated Insulin Delivery Technology NOW FDA Cleared for Pregnancy in Type 1 Diabetes

THOMSON REUTERS
·
Apr 27

Tandem Control-IQ+ wins FDA clearance for use in pregnancy with type 1 diabetes

Reuters
·
Apr 27

Tandem Diabetes price target raised to $45 from $36 at Rothschild & Co Redburn

TIPRANKS
·
Apr 24

Tandem Diabetes Care Is Maintained at Buy by TD Cowen

Dow Jones
·
Apr 20

Leveraging Rx Channel Shift and Mobi Tubeless Launch to Drive Sustainable Growth at Tandem Diabetes Care

TIPRANKS
·
Apr 20

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM) and Qiagen (QGEN)

TIPRANKS
·
Apr 15